Abstract:Increasing experimental and clinical evidence points toward a very important role for the gut microbiome and its associated metabolism in human health and disease, including in cardiovascular disorders. Free fatty acids (FFAs) are metabolically produced and utilized as energy substrates during almost every biological process in the human body. Contrary to long- and medium-chain FFAs, which are mainly synthesized from dietary triglycerides, short-chain FFAs (SCFAs) derive from the gut microbiota-mediated fermentation of indigestible dietary fiber. Originally thought to serve only as energy sources, FFAs are now known to act as ligands for a specific group of cell surface receptors called FFA receptors (FFARs), thereby inducing intracellular signaling to exert a variety of cellular and tissue effects. All FFARs are G protein-coupled receptors (GPCRs) that play integral roles in the regulation of metabolism, immunity, inflammation, hormone/neurotransmitter secretion, etc. Four different FFAR types are known to date, with FFAR1 (formerly known as GPR40) and FFAR4 (formerly known as GPR120) mediating long- and medium-chain FFA actions, while FFAR3 (formerly GPR41) and FFAR2 (formerly GPR43) are essentially the SCFA receptors (SCFARs), responding to all SCFAs, including acetic acid, propionic acid, and butyric acid. As with various other organ systems/tissues, the important roles the SCFARs (FFAR2 and FFAR3) play in physiology and in various disorders of the cardiovascular system have been revealed over the last fifteen years. In this review, we discuss the cardiovascular implications of some key (patho)physiological functions of SCFAR signaling pathways, particularly those regulating the neurohormonal control of circulation and adipose tissue homeostasis. Wherever appropriate, we also highlight the potential of these receptors as therapeutic targets for cardiovascular disorders.

Antitumor Effect of Combined Interferon and Hyperthermia in Mice

The Role of Short Chain Fatty Acids in Inflammation and Body Health

Is there any effect of fetal gender on the markers of first trimester Down's syndrome screening?

Short-Chain Fatty Acid Receptors and Cardiovascular Function

CEREBRAL HAEMODYNAMICS DURING FAILURE OF OXIDATIVE PHOSPHORYLATION FOLLOWING BIRTH ASPHYXIA

The role of short-chain fatty acids in intestinal barrier function, inflammation, oxidative stress, and colonic carcinogenesis

Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases

Regulation of immune cell function by short-chain fatty acids

Short-Chain Fatty Acids and Their Association with Signalling Pathways in Inflammation, Glucose and Lipid Metabolism

[The role of short-chain fatty acids in inflammatory bowel diseases and colorectal cancer]

Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease

Short‐chain fatty acids: bridges between diet, gut microbiota, and health

Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases

Short-chain fatty acids in diseases

Short chain fatty acids: key regulators of the local and systemic immune response in inflammatory diseases and infections

Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease

Short-chain fatty acids: linking diet, the microbiome and immunity

Percentile Distributions of Birth Weight according to Gestational Ages in Korea (2010-2012)

Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation

Role of Gut Microbiota-Generated Short-Chain Fatty Acids in Metabolic and Cardiovascular Health

Health Benefits and Side Effects of Short-Chain Fatty Acids